Y-Maze behavior after an analog of ACTH 4-9, evidence for an attentional alteration
dc.contributor.author | Chudler, R. | en_US |
dc.contributor.author | Katz, Richard J. | en_US |
dc.date.accessioned | 2006-09-11T17:45:32Z | |
dc.date.available | 2006-09-11T17:45:32Z | |
dc.date.issued | 1980-11 | en_US |
dc.identifier.citation | Katz, R. J.; Chudler, R.; (1980). "Y-Maze behavior after an analog of ACTH 4-9, evidence for an attentional alteration." Psychopharmacology 71(1): 95-96. <http://hdl.handle.net/2027.42/46418> | en_US |
dc.identifier.issn | 0033-3158 | en_US |
dc.identifier.issn | 1432-2072 | en_US |
dc.identifier.uri | https://hdl.handle.net/2027.42/46418 | |
dc.identifier.uri | http://www.ncbi.nlm.nih.gov/sites/entrez?cmd=retrieve&db=pubmed&list_uids=6256793&dopt=citation | en_US |
dc.description.abstract | Adult, male, Swiss-Webster mice were injected with either control solution or various doses of a long-acting analog of ACTH 4-9. The drug produced significant alterations in performance in an equiangular Y-maze. In comparison with control performance, both 25 and 50 μg/kg of drug produced a significant increase in repeated two-arm entries. This response pattern is consistent with the hypothesis that the drug produced a focusing of attention. | en_US |
dc.format.extent | 200532 bytes | |
dc.format.extent | 3115 bytes | |
dc.format.mimetype | application/pdf | |
dc.format.mimetype | text/plain | |
dc.language.iso | en_US | |
dc.publisher | Springer-Verlag | en_US |
dc.subject.other | Attention | en_US |
dc.subject.other | Biomedicine | en_US |
dc.subject.other | Psychiatry | en_US |
dc.subject.other | Pharmacology/Toxicology | en_US |
dc.subject.other | ACTH 4-9 | en_US |
dc.subject.other | Y-maze Performance | en_US |
dc.title | Y-Maze behavior after an analog of ACTH 4-9, evidence for an attentional alteration | en_US |
dc.type | Article | en_US |
dc.subject.hlbsecondlevel | Psychiatry | en_US |
dc.subject.hlbsecondlevel | Neurosciences | en_US |
dc.subject.hlbsecondlevel | Chemistry | en_US |
dc.subject.hlbsecondlevel | Biological Chemistry | en_US |
dc.subject.hlbtoplevel | Science | en_US |
dc.subject.hlbtoplevel | Health Sciences | en_US |
dc.description.peerreviewed | Peer Reviewed | en_US |
dc.contributor.affiliationum | Mental Health Research Institute, Department of Psychiatry, University of Michigan Medical Center, 48109, Ann Arbor, Michigan, USA | en_US |
dc.contributor.affiliationum | Mental Health Research Institute, Department of Psychiatry, University of Michigan Medical Center, 48109, Ann Arbor, Michigan, USA | en_US |
dc.contributor.affiliationumcampus | Ann Arbor | en_US |
dc.identifier.pmid | 6256793 | en_US |
dc.description.bitstreamurl | http://deepblue.lib.umich.edu/bitstream/2027.42/46418/1/213_2004_Article_BF00433260.pdf | en_US |
dc.identifier.doi | http://dx.doi.org/10.1007/BF00433260 | en_US |
dc.identifier.source | Psychopharmacology | en_US |
dc.owningcollname | Interdisciplinary and Peer-Reviewed |
Files in this item
Remediation of Harmful Language
The University of Michigan Library aims to describe library materials in a way that respects the people and communities who create, use, and are represented in our collections. Report harmful or offensive language in catalog records, finding aids, or elsewhere in our collections anonymously through our metadata feedback form. More information at Remediation of Harmful Language.
Accessibility
If you are unable to use this file in its current format, please select the Contact Us link and we can modify it to make it more accessible to you.